274 related articles for article (PubMed ID: 28138556)
1. Myocardial microRNAs associated with reverse remodeling in human heart failure.
Sucharov CC; Kao DP; Port JD; Karimpour-Fard A; Quaife RA; Minobe W; Nunley K; Lowes BD; Gilbert EM; Bristow MR
JCI Insight; 2017 Jan; 2(2):e89169. PubMed ID: 28138556
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy.
Kao DP; Lowes BD; Gilbert EM; Minobe W; Epperson LE; Meyer LK; Ferguson DA; Volkman AK; Zolty R; Borg CD; Quaife RA; Bristow MR
Circ Cardiovasc Genet; 2015 Apr; 8(2):270-83. PubMed ID: 25637602
[TBL] [Abstract][Full Text] [Related]
3. Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling.
Chen Y; Wakili R; Xiao J; Wu CT; Luo X; Clauss S; Dawson K; Qi X; Naud P; Shi YF; Tardif JC; Kääb S; Dobrev D; Nattel S
J Mol Cell Cardiol; 2014 Dec; 77():113-24. PubMed ID: 25315712
[TBL] [Abstract][Full Text] [Related]
4. Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.
Dziewięcka E; Totoń-Żurańska J; Wołkow P; Kołton-Wróż M; Pitera E; Wiśniowska-Śmiałek S; Khachatryan L; Karabinowska A; Szymonowicz M; Podolec P; Rubiś P
Adv Clin Exp Med; 2020 Mar; 29(3):285-293. PubMed ID: 32207584
[TBL] [Abstract][Full Text] [Related]
5. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
[TBL] [Abstract][Full Text] [Related]
6. Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p.
Bian C; Xu T; Zhu H; Pan D; Liu Y; Luo Y; Wu P; Li D
PLoS One; 2015; 10(12):e0144877. PubMed ID: 26658785
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury.
Park KM; Teoh JP; Wang Y; Broskova Z; Bayoumi AS; Tang Y; Su H; Weintraub NL; Kim IM
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H371-83. PubMed ID: 27288437
[TBL] [Abstract][Full Text] [Related]
8. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200
[TBL] [Abstract][Full Text] [Related]
9. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
Li M; Chen X; Chen L; Chen K; Zhou J; Song J
J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of SERCA2a and miR-25-3p/5p in myocardium of rats with heart failure and therapeutic effects of Xiefei Lishui recipe].
Wu JB; Ye XH; Xian SX; Dong MG
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Feb; 33(2):146-150. PubMed ID: 29931923
[TBL] [Abstract][Full Text] [Related]
12. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
[TBL] [Abstract][Full Text] [Related]
13. Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy.
Suwa M; Ito T; Kobashi A; Yagi H; Terasaki F; Hirota Y; Kawamura K
Am Heart J; 2000 May; 139(5):905-12. PubMed ID: 10783226
[TBL] [Abstract][Full Text] [Related]
14. Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy.
Iyengar S; Haas G; Lamba S; Orsinelli DA; Babu GJ; Ferketich AK; Yamokoski L; Periasamy M; Abraham WT
J Card Fail; 2007 May; 13(4):304-11. PubMed ID: 17517351
[TBL] [Abstract][Full Text] [Related]
15. A cardiac myocyte-restricted Lin28/let-7 regulatory axis promotes hypoxia-mediated apoptosis by inducing the AKT signaling suppressor PIK3IP1.
Joshi S; Wei J; Bishopric NH
Biochim Biophys Acta; 2016 Feb; 1862(2):240-51. PubMed ID: 26655604
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
[TBL] [Abstract][Full Text] [Related]
17. Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy.
Cheng X; Jian D; Xing J; Liu C; Liu Y; Cui C; Li Z; Wang S; Li R; Ma X; Wang Y; Gu X; Ge Z; Tang H; Liu L
Clin Transl Med; 2023 May; 13(5):e1258. PubMed ID: 37138538
[TBL] [Abstract][Full Text] [Related]
18. ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.
Feyen E; Ricke-Hoch M; Van Fraeyenhove J; Vermeulen Z; Scherr M; Dugaucquier L; Viereck J; Bruyns T; Thum T; Segers VFM; Hilfiker-Kleiner D; De Keulenaer GW
Circ Heart Fail; 2021 Jul; 14(7):e006898. PubMed ID: 34247489
[TBL] [Abstract][Full Text] [Related]
19. A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
Bayoumi AS; Park KM; Wang Y; Teoh JP; Aonuma T; Tang Y; Su H; Weintraub NL; Kim IM
J Mol Cell Cardiol; 2018 Jan; 114():72-82. PubMed ID: 29122578
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
Ahmet I; Lakatta EG; Talan MI
Heart Fail Rev; 2005 Dec; 10(4):289-96. PubMed ID: 16583177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
